Revitalist Lifestyle and Wellness CEO Kathryn A. Walker to Speak at The AANA Annual Congress on Psychedelics in Anesthesia
Revitalist Lifestyle and Wellness CEO Kathryn A. Walker to Speak at The AANA Annual Congress on Psychedelics in Anesthesia
Vancouver, British Columbia--(Newsfile Corp. - July 31, 2024) - Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) (the "Company") announces that Kathryn A. Walker, CEO of Revitalist Lifestyle and Wellness Ltd., will be presenting at the American Association of Nurse Anesthesiologists (AANA) Annual Congress. The event will take place from August 2-6, 2024, at the San Diego Convention Center.
Revitalist Lifestyle and Wellness Ltd.(CSE:CALM)(OTC:RVLWF)(FSE:4DO)(下稱“公司”)宣佈,該公司首席執行官Kathryn A. Walker 將在美國麻醉護士協會(AANA)年度大會上發表演講。本次大會將於2024年8月2日至8月6日在聖迭戈會議中心舉行。
Walker's session, "Entering the World of Psychedelics as an Anesthesia Professional," is scheduled for August 5, 2024, from 3:30 PM to 4:30 PM PT in Hall B on the Lower Level.
Walker的主題演講"作爲麻醉專業人士進入迷幻藥物的世界"定於2024年8月5日下午3:30至4:30在下層的B廳舉行。
In this session, Walker will delve into the emerging field of psychedelic medicines and their relevance to nurse anesthetists. With psychedelic therapies rapidly advancing in both medical and mental health contexts, Walker will discuss how these medications can enhance anesthesia practices, including medication delivery techniques and therapeutic communication styles.
在這個主題演講中,Walker將深入探討迷幻藥物領域的新興療法及其對護士麻醉師的相關性。隨着迷幻療法在醫療和心理健康領域不斷推進,Walker將探討這些藥物如何增強麻醉實踐,包括用藥技巧和治療性溝通風格。
The session will cover the following learning objectives:
此次會議將涵蓋以下學習目標:
- Identification of psychedelic medicines and their legal approval dates at both federal and state levels.
- Understanding the pharmacologic nature of psychedelic medications and their applications in mental health, pain syndromes, and neurodegenerative diseases.
- General concepts for working in the outpatient community and the requirements for meeting state and federal guidelines as a practitioner.
- 識別聯邦和州級迷幻藥物及其合法批准日期。
- 了解迷幻藥物的藥理性質及其在心理健康、疼痛綜合症和神經退行性疾病中的應用。
- 普遍應用於門診社區的基本概念以及作爲從業者遵循聯邦和州級指南的要求。
"Psychotropic medications are becoming a transformative element in healthcare, offering new opportunities for improving mental health and managing complex conditions," said Kathryn A. Walker. "Nurse anesthetists are uniquely equipped to lead in this evolving field, and our session will provide valuable insights into how CRNAs can leverage their expertise to contribute to this exciting area."
"精神藥物正在成爲醫療保健中的一種變革性元素,爲改善心理健康和管理複雜疾病提供了新機會,"Kathryn A. Walker表示。"護士麻醉師在這個不斷髮展的領域中擁有獨特的領導能力,我們的演講將爲CRNA如何利用他們的專業知識爲這個令人興奮的領域做出貢獻提供有價值的見解。"
Attendees can earn Class A credit by participating in the live session in-person or via live webinar. Please note that recorded sessions will not be available immediately following the Congress due to CE guidelines.
參加現場演講或通過網絡研討會參加演講的與會者可以獲得A類學分。請注意,由於CE準則,錄製的演講將不會立即提供。
For more information and to register for the event, please visit AANA Annual Congress or access the presentation details directly at AANA 2024 Presentation.
欲了解更多信息或註冊活動,請訪問AANA年會或直接訪問AANA 2024演示文稿詳情。
About Revitalist Lifestyle and Wellness Ltd. Revitalist (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) is a mental health and wellness company focused on comprehensive care in the ketamine wellness space offering innovative, evidenced based services. The Company operates through physical locations and virtual offices across the United States and the British Virgin Islands.
關於Revitalist Lifestyle and Wellness Ltd. Revitalist(CSE:CALM)(OTC:RVLWF)(FSE:4DO)Revitalist Lifestyle and Wellness Ltd.(CSE:CALM)(OTC:RVLWF)(FSE:4DO)是一家專注於麻醉科藥物完整護理的心理健康和健康公司,提供創新的、證據支持的服務。公司在美國和英屬維爾京群島的實體位置和虛擬辦公室運營。
Founded and led by Kathryn Walker, an advanced provider in the psychedelic space, Revitalist is at the forefront of this emerging field. Visit Revitalist.com for more information.
由迷幻空間高級供應商Kathryn Walker創立和領導的Revitalist處於這個新興領域的前沿。欲了解更多信息,請訪問Revitalist.com。
Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to known and unknown risks, uncertainties and assumptions and accordingly, actual results and future events could differ materially from those expressed or implied in such statements. You are hence cautioned not to place undue reliance on forward-looking statements. All statements other than statements of present or historical fact are forward-looking statements, including statements with respect to Revitalist' future business plans and partnerships. Forward-looking statements include words or expressions such as "proposed", "anticipated", "will", "subject to", "near future", "in the event", "would", "expect", "prepared to" and other similar words or expressions and include, but are not limited to: the ability of Revitalist to secure patent protection; the regulatory environment in which Revitalist operates; the ability of Revitalist to carry out its business plans and unforeseen challenges in carrying out such plans; trends in the future use of psychedelics; general business, economic, competitive, political and social uncertainties; the state of capital markets; and other unforeseen events, developments, or factors causing any of the aforesaid expectations, assumptions, and other factors ultimately being inaccurate or irrelevant. The forward-looking information contained in this news release is expressly qualified by this cautionary statement. We disclaim any obligation to update or revise these forward-looking statements, except as required by applicable law.
前瞻性聲明
本新聞稿包含前瞻性陳述。前瞻性陳述基於管理層在發表陳述時的意見和估計,並受已知和未知的風險、不確定性和假設的影響,因此實際結果和未來事件可能與這些陳述中表達的結果或預期有所不同。因此,您應該謹慎對待前瞻性陳述。除了當前或歷史事實陳述之外的所有陳述均爲前瞻性陳述,包括與Revitalist未來業務計劃和合作夥伴有關的陳述。前瞻性陳述包括多種詞或表達方式,如"擬議"、"預計"、"將", "受制於", "近期"、"在事件中"、"將會", "期望", "準備好了", 以及其他類似的詞或表達方式,包括但不限於:Revitalist獲得專利保護的能力;Revitalist運營的監管環境;Revitalist實施其業務計劃和實施這些計劃時的意外挑戰;未來迷幻藥物的使用趨勢;一般的商業、經濟、競爭、政治和社會不確定性;資本市場的狀況;和其他未預料的事件、行動或因素,導致上述任何期望、假設或其他因素最終變得不準確或無關。本新聞稿中包含的前瞻性信息應受到此警示性聲明的明確限制。我們否認任何更新或修訂這些前瞻性陳述的義務,除非適用法律要求。
PR Contact
Kristina Spionjak
pr@hlthcommunications.com
公關聯繫方式
Kristina Spionjak
pr@hlthcommunications.com
譯文內容由第三人軟體翻譯。